Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
The American Journal of Nursing
|
October 30, 2001
Nursing trauma
W K Stevens
Biochemistry
|
March 23, 1993
Structural changes in the protease domain of prothrombin upon activation as assessed by N-bromosuccinimide modification of tryptophan residues in prethrombin-2 and thrombin
W K Stevens, M E Nesheim
The Journal of Hygiene
|
June 1, 1971
The evaluation of a live salmonella vaccine in mice and chickens
V A Knivett, W K Stevens
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire
|
May 1, 1988
Effect of amino acids on choline uptake and phosphatidylcholine biosynthesis in the isolated hamster heart
G M Hatch, W K Stevens, P C Choy
The Journal of Biological Chemistry
|
April 25, 2000
Roles of thermal instability and proteolytic cleavage in regulation of activated thrombin-activable fibrinolysis inhibitor
M B Boffa, R Bell, W K Stevens, et al.
The Journal of Biological Chemistry
|
April 5, 1996
Calcium ion modulation of meizothrombin autolysis at Arg55-Asp56 and catalytic activity
W K Stevens, H F Côté, R T MacGillivray, et al.
Biochemistry
|
May 13, 1999
Conformation of a Cdc42/Rac interactive binding peptide in complex with Cdc42 and analysis of the binding interface
W K Stevens, W Vranken, N Goudreau, et al.
The Journal of Biological Chemistry
|
April 15, 1994
Characterization of a stable form of human meizothrombin derived from recombinant prothrombin (R155A, R271A, and R284A)
H C Côté, W K Stevens, L Bajzar, et al.
The Journal of Biological Chemistry
|
June 1, 2000
Fluorescence properties and functional roles of tryptophan residues 60d, 96, 148, 207, and 215 of thrombin
R Bell, W K Stevens, Z Jia, et al.
The Journal of Biological Chemistry
|
March 7, 1997
Functional characterization of recombinant human meizothrombin and Meizothrombin(desF1). Thrombomodulin-dependent activation of protein C and thrombin-activatable fibrinolysis inhibitor (TAFI), platelet aggregation, antithrombin-III inhibition
H C Côté, L Bajzar, W K Stevens, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
The American Journal of Nursing
|
October 30, 2001
Nursing trauma
W K Stevens
Biochemistry
|
March 23, 1993
Structural changes in the protease domain of prothrombin upon activation as assessed by N-bromosuccinimide modification of tryptophan residues in prethrombin-2 and thrombin
W K Stevens, M E Nesheim
The Journal of Hygiene
|
June 1, 1971
The evaluation of a live salmonella vaccine in mice and chickens
V A Knivett, W K Stevens
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire
|
May 1, 1988
Effect of amino acids on choline uptake and phosphatidylcholine biosynthesis in the isolated hamster heart
G M Hatch, W K Stevens, P C Choy
The Journal of Biological Chemistry
|
April 25, 2000
Roles of thermal instability and proteolytic cleavage in regulation of activated thrombin-activable fibrinolysis inhibitor
M B Boffa, R Bell, W K Stevens, et al.
The Journal of Biological Chemistry
|
April 5, 1996
Calcium ion modulation of meizothrombin autolysis at Arg55-Asp56 and catalytic activity
W K Stevens, H F Côté, R T MacGillivray, et al.
Biochemistry
|
May 13, 1999
Conformation of a Cdc42/Rac interactive binding peptide in complex with Cdc42 and analysis of the binding interface
W K Stevens, W Vranken, N Goudreau, et al.
The Journal of Biological Chemistry
|
April 15, 1994
Characterization of a stable form of human meizothrombin derived from recombinant prothrombin (R155A, R271A, and R284A)
H C Côté, W K Stevens, L Bajzar, et al.
The Journal of Biological Chemistry
|
June 1, 2000
Fluorescence properties and functional roles of tryptophan residues 60d, 96, 148, 207, and 215 of thrombin
R Bell, W K Stevens, Z Jia, et al.
The Journal of Biological Chemistry
|
March 7, 1997
Functional characterization of recombinant human meizothrombin and Meizothrombin(desF1). Thrombomodulin-dependent activation of protein C and thrombin-activatable fibrinolysis inhibitor (TAFI), platelet aggregation, antithrombin-III inhibition
H C Côté, L Bajzar, W K Stevens, et al.
Page
of 1